REVIEW ARTICLE |
|
Year : 2016 | Volume
: 6
| Issue : 1 | Page : 8-16 |
|
The current approach of atrial fibrillation management
Anish Amin, Aseel Houmsse, Abiodun Ishola, Jaret Tyler, Mahmoud Houmsse
Department of Cardiovascular Medicine, The Ohio State University Medical Center, Columbus, Ohio, USA
Correspondence Address:
Mahmoud Houmsse Department of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Davis Heart and Lung Research Institute, Suite 200, 472 W 12th Avenue, Columbus, Ohio 43210 USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2231-0770.173580
|
|
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice. Aging populations coupled with improved outcomes for many chronic medical conditions has led to increases in AF diagnoses. AF is also known to be associated with an increased risk of adverse events such as transient ischemic attack, ischemic stroke, systemic embolism, and death. This association is enhanced in select populations with preexisting comorbid conditions such as chronic heart failure. The aim of this review is to highlight the advances in the field of cardiology in the management of AF in both acute and long-term settings. We will also review the evolution of anticoagulation management over the past few years and landmark trials in the development of novel oral anticoagulants (NOACs), reversal agents for new NOACs, nonpharmacological options to anticoagulation therapy, and the role of implantable loop recorder in AF management. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|